Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging

Cancer

Volumn 98, Issue 3, 2003, Pages 468-473

  Bedrosian, Isabelle ^a   Mick, Rosemarie ^a   Orel, Susan G ^a   Schnall, Mitchell ^a   Reynolds, Carol ^b   Spitz, Francis R ^a   Callans, Linda S ^a   Buzby, Gordon P ^a   Rosato, Ernest F ^a   Fraker, Douglas L ^a   Czerniecki, Brian J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Breast carcinoma; Magnetic resonance imaging; Staging; Surgery

Indexed keywords

ARTICLE; BREAST CARCINOMA; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC ACCURACY; FEMALE; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TREATMENT PLANNING;

BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM, RESIDUAL; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 0038299193     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.11490     Document Type: Article

References (36)

1. Kurtz J, Jacquemier J, Amalric R, et al. Breast conserving therapy for macroscopically multiple cancers. Ann Surg. 1990;212:38-44.
2. Kurtz J. Factors influencing the risk of local recurrence in the breast. Eur J Cancer. 1992;28:660-666.
3. Holland R, Veling S, Mravunac M, Hendriks J. Histlogic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer. 1985;56:979-990.
4. Anastassiades O, Iakovou E, Stavridou N, Gogas J, Karameris A. Multicentricity in breast cancer. A study of 366 cases. Am J Clin Pathol. 1993;99:238-243.
5. Schwartz G, Patchesfsky A, Feig S, Shaber G, Schwartz A. Multicentricity of non-palpable breast cancer. Cancer. 1980;45:2913-2916.
6. Vaidya J, Vyas J, Chinoy R, Merchant N, Sharma O, Mittra I. Multicentricity of breast cancer: whole organ analysis and clinical implications. Br J Cancer. 1996;74:820-824.
7. Gilles R, Guinebretiere J, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis with contrast enhanced subtraction dynamic MR imaging. Radiology. 1994;191:625-631.
8. Harms S, Flaming D, Hesley K, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology. 1993;187:493-501.
9. Orel S, Schnall M, Powell C, et al. Staging of suspected breast cancer: effect of MR imaging and MR guided biopsy. Radiology. 1995;196:115-122.
10. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast enhanced MR imaging on the therapeutic approach. Radiology. 1999;213:881-888.
11. Tan J, Orel S, Schnall M, Schultz D, Solin L. Role of magnetic resonance imaging and magnetic resonance imaging-guided surgery in the evaluation of patients with early-stage breast cancer for breast conservation treatment. Am J Clin Oncol. 1999;22:414-418.
12. Tillman GF, Orel SG, Schnall MD, Schultz DJ, Tan JE, Solin LJ. Effect of breast magnetic resonance imaging on the clinical management of women with early-stage breast carcinoma. J Clin Oncol. 2002;20:3413-3423.
13. Orel S, Weinstein S, Schnall M, et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology. 1999;212:543-549.
14. Olson J, Morris E, Van Zee K, Linehan D, Borgen P. Magnetic resonance imaging facilitates breast conservation for occult breast cancer. Ann Surg Oncol. 2000;7:411-415.
15. Orel S, Reynolds C, Schnall M, Solin L, Fraker D, Sullivan D. Breast carcinoma: MR imaging before re-excisional biopsy. Radiology. 1997;205:429-436.
16. Bedrosian I, Schlencker J, Spitz FR, et al. Magnetic resonance imaging-guided biopsy of mammographically and clinically occult breast lesions. Ann Surg Oncol. 2002;9:457-461.
17. Kuhl C, Elevelt A, Leutner C, Gieseke J, Pakos E, Schild H. Interventional breast MR imaging: clinical use of a stereotatic localization and biopsy device. Radiology. 1997;204:667-675.
18. Orel S, Schnall M, LiVolsi V, Troupin R. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology. 1994;190:485-493.
19. Piccoli C. Contrast enhanced breast MRI: factors affecting sensitivity and specificity. Eur Radiol. 1997;7(Suppl 5):281-288.
20. Drew P, Chatterjee S, Turnbull L, et al. Dynamic contrast enhanced magnetic resonance imaging of the breast is superior to triple assessment for the preoperative detection of multifocal breast cancer. Ann Surg Oncol. 1999;6:599-603.
21. Boetes C, Mus R, Holland R, et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology. 1995;197:743-747.
22. Weinstein S, Orel S, Heller R, et al. MR imaging of the breast in patients with invasive lobular carcinoma. AJR Am J Roentgenol. 2001;176:399-406.
23. Rodenko G, Harms S, Pruneda J, et al. MR imaging in the management before surgery of lobular carcinoma of the breast: correlation with pathology. AJR Am J Roentgenol. 1996;167:1415-1419.
24. Sastre-Garau X, Jouve M, Asselain B, et al. Infiltrating lobular carcinoma of the breast. Clinicopatholgic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns. Cancer. 1996;77:113120.
25. Hilleren D, Andersson I, Lindholm K, Linnell F. Invasive lobular carcinoma: mammographic findings in a 10-year experience. Radiology. 1991;178:149-154.
26. Krecke K, Gisvold J. Invasive lobular carcinoma of the breast: mammographic findings and extent of disease at diagnosis in 184 patients. AJR Am J Roentgenol. 1993;161:957-960.
27. Helvie M, Paramagul C, Oberman H, Adler D. Invasive lobular carcinoma. Imaging features and clinical detection. Invest Radiol. 1993;28:202-207.
28. Butler R, Venta L, Wiley E, Ellis R, Dempsey P, Rubin E. Sonographic evaluation of infiltrating lobular carcinoma. AJR Am J Roentgenol. 1999;172:325-330.
29. Paramagul C, Helvie M, Adler D. Invasive lobular carcinoma: sonographic appearance and role of sonography in improving diagnostic sensitivity. Radiology. 1995;195:231-234.
30. Lesser M, Rosen P, Kinne D. Multicentricity and bilaterality in invasive breast carcinoma. Surgery. 1982;91:234-240.
31. Chung MA, Cole B, Wanebo HJ, Bland KI, Chang HR. Optimal surgical treatment of invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:545-550.
32. Bouvet M, Ollila DW, Hunt KK, et al. Role of conservation therapy for invasive lobular carcinoma of the breast. Ann Surg Oncol. 1997;4:650-654.
33. Poen JC, Tran L, Juillard G, et al. Conservation therapy for invasive lobular carcinoma of the breast. Cancer. 1992;69:2789-2795.
34. Holland PA, Shah A, Howell A, Baildam AD, Bundred NJ. Lobular carcinoma of the breast can be managed by breast-conserving therapy. Br J Surg. 1995;82:1364-1366.
35. Park C, Mitsumori M, Nixon A, et al. Outcome at 8 years after breast conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol. 2000;18:1668-1675.
36. Fowble B, Solin L, Schultz D, Goodman R. Ten year results of conservative surgery and irradiation for Stage I and II breast cancer. Int J Radiat Oncol Biol Phys. 1991;21:269-277.